February 27, 2026

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Biotech Innovator with a 10.77% Potential Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE), a promising player in the biotechnology sector, has caught the attention of investors with its innovative approach to treating renal, cardiovascular,..

COMPASS Pathways (CMPS) Stock Analysis: Unveiling a Potential 164.89% Upside in the Psychedelic Therapy Space

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering company in the development of innovative mental health therapies, is capturing the attention of investors with its promising product..

Valneva SE (VALN) Stock Analysis: Potential Upside Amidst Challenging Metrics

Valneva SE (NASDAQ: VALN), a French biotechnology firm specializing in vaccines for infectious diseases, has garnered attention from investors, particularly due to its promising pipeline of..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a Potential 205% Upside in the Biotech Sector

Investors eyeing the biotechnology sector should take a close look at Niagen Bioscience, Inc. (NAGE), a company poised for substantial growth. With a market cap of..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Amidst Challenges

Sonida Senior Living, Inc. (SNDA), operating within the healthcare sector as a key player in the medical care facilities industry, is currently under the spotlight for..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unveiling a Potential 116% Upside in Healthcare Innovation

Organogenesis Holdings Inc. (NASDAQ: ORGO), a leading regenerative medicine company based in Canton, Massachusetts, presents a compelling narrative for investors with a keen interest in healthcare..

Cel-Sci Corporation (CVM): Unpacking the 832% Upside Potential for This Biotech Innovator

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company based in Vienna, Virginia, is making waves in the healthcare sector with its groundbreaking approach to immunotherapy. Specializing..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Powerhouse with 76% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is a clinical-stage biopharmaceutical company that has captured the attention of investors due to its promising pipeline in the healthcare..

MBX Biosciences, Inc. (MBX) Stock Report: Analyzing a 74% Potential Upside in the Biotech Sector

MBX Biosciences, Inc. (NASDAQ: MBX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to treating endocrine and metabolic disorders...

Cogent Biosciences, Inc. (COGT)

⚠️ No article content returned.

..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Unveiling a Promising 50.96% Upside for Investors

Investors eyeing the healthcare sector may find Castle Biosciences, Inc. (NASDAQ: CSTL) an intriguing opportunity, particularly given its notable potential upside of 50.96%. With a focus..

Spyre Therapeutics, Inc. (SYRE): Investor Outlook Amid a 35% Potential Upside

Spyre Therapeutics, Inc. (NASDAQ: SYRE) stands as a compelling player in the biotechnology sector, primarily focused on developing innovative treatments for inflammatory bowel disease (IBD) and..

KalVista Pharmaceuticals, Inc. (KALV): Investor Outlook with a Promising 115% Upside Potential

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) presents an intriguing opportunity for investors looking to delve into the biotechnology sector, particularly within the realm of innovative therapies for..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Challenges with Strategic Home Health and Hospice Services

Enhabit, Inc. (EHAB), a notable player in the U.S. healthcare sector, operates within the medical care facilities industry, primarily offering comprehensive home health and hospice services...

Arvinas, Inc. (ARVN) Stock Analysis: Navigating the 6.50% Upside Potential Amidst Clinical Innovations

Arvinas, Inc. (NASDAQ: ARVN) stands as a pioneering player in the biotechnology sector, with a market capitalization of $982.33 million. Known for its cutting-edge work in..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 505% Potential Upside in the Biotech Sector

In the ever-evolving landscape of biotechnology, Upstream Bio, Inc. (NASDAQ: UPB) stands out as a promising player for investors eyeing the healthcare sector. With a focus..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a Potential 189% Upside in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM), a clinical-stage biopharmaceutical company, is captivating the attention of investors with a remarkable potential upside of 189.71%. This Massachusetts-based firm, specializing in..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating a Challenging Biotech Landscape with a 2.99% Potential Upside

Investors in the biotechnology sector are accustomed to navigating volatility, and Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is no exception. This Boston-based biotech innovator, with a..

GH Research PLC (GHRS) Stock Analysis: Exploring a Potential 115% Upside in the Biotech Arena

Investors on the lookout for high-growth opportunities in the biotechnology sector might find GH Research PLC (NASDAQ: GHRS) an intriguing prospect. Based in Dublin, Ireland, this..

EyePoint, Inc. (EYPT) Stock Analysis: Unpacking the 103% Potential Upside

EyePoint, Inc. (NASDAQ: EYPT) stands out in the biotechnology sector with a striking 103.43% potential upside, according to analyst ratings. This Massachusetts-based company is gaining traction..

Search

Funds

February 27, 2026

Search

Funds

February 27, 2026

FTSE 100

Funds